FibroGen Inc (FGEN)
0.3954
+0.01
(+2.12%)
USD |
NASDAQ |
Nov 22, 16:00
0.40
0.00 (0.00%)
After-Hours: 20:00
FibroGen Revenue (Annual): 147.75M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 147.75M |
| December 31, 2022 | 140.73M |
| December 31, 2021 | 235.31M |
| December 31, 2020 | 176.32M |
| December 31, 2019 | 256.58M |
| December 31, 2018 | 212.96M |
| Date | Value |
|---|---|
| December 31, 2017 | 131.00M |
| December 31, 2016 | 183.19M |
| December 31, 2015 | 180.83M |
| December 31, 2014 | 137.60M |
| December 31, 2013 | 102.17M |
| December 31, 2012 | 65.93M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
140.73M
Minimum
2022
256.58M
Maximum
2019
191.34M
Average
176.32M
Median
2020
Revenue (Annual) Benchmarks
| Biomarin Pharmaceutical Inc | 2.419B |
| Arbutus Biopharma Corp | 18.14M |
| GlycoMimetics Inc | 0.01M |
| Cidara Therapeutics Inc | 63.90M |
| Cue Biopharma Inc | 5.49M |